Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361888
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-03-26
Brief Title:
A Phase IIIII Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Sponsor:
Organization:
Hutchmed